Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Azithromycin in PPROM
NCT07669207Phase 4Recruiting
- Start
- Aug 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in preterm premature rupture of membranes (pPROM). Started Aug 2026; status: recruiting.
02
Drugs
azithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT07669207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669207.